Log In
Print
BCIQ
Print
Print this Print this
 

Aptiom, Zebinix, eslicarbazepine acetate (BIA 2-093, SEP-0002093) (formerly Stedesa)

Also known as: Exalief

  Manage Alerts
Collapse Summary General Information
Company Bial-Portela & Ca. S.A.
DescriptionVoltage-gated sodium and T-type calcium channel blocker
Molecular Target Sodium channel ; Calcium channel T-type
Mechanism of ActionNa channel blocker
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$121.1M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today